These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 30247786)

  • 1. Comparison of echocardiographic parameters in Fabry cardiomyopathy and light-chain cardiac amyloidosis.
    Marek J; Palecek T; Magne J; Lavergne D; Boulogne C; Fadel BM; Jaccard A; Linhart A; Mohty D
    Echocardiography; 2018 Nov; 35(11):1755-1763. PubMed ID: 30247786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systolic and diastolic function assessment in fabry disease patients using speckle-tracking imaging and comparison with conventional echocardiographic measurements.
    Shanks M; Thompson RB; Paterson ID; Putko B; Khan A; Chan A; Becher H; Oudit GY
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1407-14. PubMed ID: 24125876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early diastolic mitral annular velocity and color M-mode flow propagation velocity in the evaluation of left ventricular diastolic function in patients with Fabry disease.
    Palecek T; Linhart A; Lubanda JC; Magage S; Karetova D; Bultas J; Aschermann M
    Heart Vessels; 2006 Jan; 21(1):13-9. PubMed ID: 16440143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The diagnostic performance of cardiac magnetic resonance in detection of myocardial involvement in AL amyloidosis.
    Fikrle M; Palecek T; Masek M; Kuchynka P; Straub J; Spicka I; Rysava R; Linhart A
    Clin Physiol Funct Imaging; 2016 May; 36(3):218-24. PubMed ID: 25393773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Left ventricular assessment in patients with systemic light chain amyloidosis: a 3-dimensional speckle tracking transthoracic echocardiographic study.
    Pradel S; Magne J; Jaccard A; Fadel BM; Boulogne C; Salemi VMC; Damy T; Aboyans V; Mohty D
    Int J Cardiovasc Imaging; 2019 May; 35(5):845-854. PubMed ID: 30623354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic features of Fabry cardiomyopathy-Comparison with hypertrophy-matched sarcomeric hypertrophic cardiomyopathy.
    Militaru S; Jurcuț R; Adam R; Roşca M; Ginghina C; Popescu BA
    Echocardiography; 2019 Nov; 36(11):2041-2049. PubMed ID: 31661576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal strain of left ventricular basal segments and E/e' ratio differentiate primary cardiac amyloidosis at presentation from hypertensive hypertrophy: an automated function imaging study.
    Schiano-Lomoriello V; Galderisi M; Mele D; Esposito R; Cerciello G; Buonauro A; Della Pepa R; Picardi M; Catalano L; Trimarco B; Pane F
    Echocardiography; 2016 Sep; 33(9):1335-43. PubMed ID: 27277827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Right Ventricular Hypertrophy, Systolic Function, and Disease Severity in Anderson-Fabry Disease: An Echocardiographic Study.
    Graziani F; Laurito M; Pieroni M; Pennestrì F; Lanza GA; Coluccia V; Camporeale A; Pedicino D; Verrecchia E; Manna R; Crea F
    J Am Soc Echocardiogr; 2017 Mar; 30(3):282-291. PubMed ID: 28069318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of left atrial reservoir function with left atrial structural remodeling related to left ventricular dysfunction in asymptomatic patients with hypertension: evaluation by two-dimensional speckle-tracking echocardiography.
    Miyoshi H; Oishi Y; Mizuguchi Y; Iuchi A; Nagase N; Ara N; Oki T
    Clin Exp Hypertens; 2015; 37(2):155-65. PubMed ID: 25050647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac Amyloidosis Shows Decreased Diastolic Function as Assessed by Echocardiographic Parameterized Diastolic Filling.
    Salman K; Cain PA; Fitzgerald BT; Sundqvist MG; Ugander M
    Ultrasound Med Biol; 2017 Jul; 43(7):1331-1338. PubMed ID: 28433439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spirito-Maron echocardiographic score: a marker for morphological and physiological assessment of patients with hypertrophic cardiomyopathy.
    Rangel I; Gonçalves A; de Sousa C; Correia AS; Pinho T; Madureira AJ; Martins E; Cardoso JS; Macedo F; Maciel MJ
    Echocardiography; 2014 Jul; 31(6):708-15. PubMed ID: 24460546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation of light-chain cardiac amyloidosis from hypertrophic cardiomyopathy using myocardial mechanical parameters by velocity vector imaging echocardiography.
    Zhang L; Zhou X; Wang J; Mu Y; Liu B; Lv W; Wang Y; Liu H; Liu H; Zhi G
    Int J Cardiovasc Imaging; 2017 Apr; 33(4):499-507. PubMed ID: 27878699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simplified apical four-chamber view evaluation of relative apical sparing of longitudinal strain in diagnosing AL amyloid cardiomyopathy.
    Fikrle M; Palecek T; Marek J; Kuchynka P; Linhart A
    Echocardiography; 2018 Nov; 35(11):1764-1771. PubMed ID: 30225879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced cardiac amyloidosis associated with normal interventricular septal thickness: an uncommon presentation of infiltrative cardiomyopathy.
    Suresh R; Grogan M; Maleszewski JJ; Pellikka PA; Hanna M; Dispenzieri A; Pereira NL
    J Am Soc Echocardiogr; 2014 Apr; 27(4):440-7. PubMed ID: 24444660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of left ventricular rotational mechanics in patients with systemic amyloidosis, systemic hypertension and normal left ventricular mass.
    Cappelli F; Porciani MC; Bergesio F; Perfetto F; De Antoniis F; Cania A; Tronconi F; Ricceri I; Padeletti L
    Clin Physiol Funct Imaging; 2011 Mar; 31(2):159-65. PubMed ID: 21310001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial enlargement and reduced atrial compliance occurs early in Fabry cardiomyopathy.
    Boyd AC; Lo Q; Devine K; Tchan MC; Sillence DO; Sadick N; Richards DA; Thomas L
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1415-23. PubMed ID: 24094560
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease.
    Cioffi G; Viapiana O; Ognibeni F; Dalbeni A; Gatti D; Mazzone C; Faganello G; Di Lenarda A; Adami S; Rossini M
    J Am Soc Echocardiogr; 2016 Jul; 29(7):689-98. PubMed ID: 26922258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent left ventricular dilatation in tachycardia-induced cardiomyopathy patients after appropriate treatment and normalization of ejection fraction.
    Dandamudi G; Rampurwala AY; Mahenthiran J; Miller JM; Das MK
    Heart Rhythm; 2008 Aug; 5(8):1111-4. PubMed ID: 18675220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraventricular dyssynchrony in light chain amyloidosis: a new mechanism of systolic dysfunction assessed by 3-dimensional echocardiography.
    Migrino RQ; Harmann L; Woods T; Bright M; Truran S; Hari P
    Cardiovasc Ultrasound; 2008 Aug; 6():40. PubMed ID: 18687125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.